These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 39160490)

  • 21. Demographic and socioenvironmental predictors of premorbid marijuana use among patients with first-episode psychosis.
    Pauselli L; Birnbaum ML; Vázquez Jaime BP; Paolini E; Kelley ME; Broussard B; Compton MT
    Schizophr Res; 2018 Jul; 197():544-549. PubMed ID: 29397281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The profile of psychiatric symptoms exacerbated by methamphetamine use.
    McKetin R; Dawe S; Burns RA; Hides L; Kavanagh DJ; Teesson M; McD Young R; Voce A; Saunders JB
    Drug Alcohol Depend; 2016 Apr; 161():104-9. PubMed ID: 26874915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive impairment in methamphetamine users with recent psychosis: A cross-sectional study in Thailand.
    Srisurapanont M; Lamyai W; Pono K; Indrakamhaeng D; Saengsin A; Songhong N; Khuwuthyakorn P; Jantamo P
    Drug Alcohol Depend; 2020 May; 210():107961. PubMed ID: 32302795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical features of inpatients with methamphetamine-induced psychosis.
    Fasihpour B; Molavi S; Shariat SV
    J Ment Health; 2013 Aug; 22(4):341-9. PubMed ID: 23323572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors affecting severity of positive and negative symptoms of psychosis in a polysubstance using population with psychostimulant dependence.
    Willi TS; Honer WG; Thornton AE; Gicas K; Procyshyn RM; Vila-Rodriguez F; Panenka WJ; Aleksic A; Leonova O; Jones AA; MacEwan GW; Barr AM
    Psychiatry Res; 2016 Jun; 240():336-342. PubMed ID: 27138828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary and substance-induced psychotic disorders in methamphetamine users.
    Hides L; Dawe S; McKetin R; Kavanagh DJ; Young RM; Teesson M; Saunders JB
    Psychiatry Res; 2015 Mar; 226(1):91-6. PubMed ID: 25677394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabis and Alcohol Abuse Among First Psychotic Episode Inpatients.
    Katz G; Kunyvsky Y; Hornik-Lurie T; Raskin S; Abramowitz MZ
    Isr J Psychiatry Relat Sci; 2016; 53(3):10-15. PubMed ID: 28492376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistence of psychotic symptoms as an indicator of cognitive impairment in methamphetamine users.
    Chen CK; Lin SK; Chen YC; Huang MC; Chen TT; Ree SC; Wang LJ
    Drug Alcohol Depend; 2015 Mar; 148():158-64. PubMed ID: 25601645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis.
    Chen CK; Lin SK; Sham PC; Ball D; Loh EW; Hsiao CC; Chiang YL; Ree SC; Lee CH; Murray RM
    Psychol Med; 2003 Nov; 33(8):1407-14. PubMed ID: 14672249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First psychotic episode risk markers for primary psychosis amongst people who use methamphetamine.
    McKetin R; Hides L; Kavanagh DJ; Saunders JB; Dawe S
    Schizophr Res; 2018 Sep; 199():456-457. PubMed ID: 29680188
    [No Abstract]   [Full Text] [Related]  

  • 32. Marijuana use in the immediate 5-year premorbid period is associated with increased risk of onset of schizophrenia and related psychotic disorders.
    Kelley ME; Wan CR; Broussard B; Crisafio A; Cristofaro S; Johnson S; Reed TA; Amar P; Kaslow NJ; Walker EF; Compton MT
    Schizophr Res; 2016 Mar; 171(1-3):62-7. PubMed ID: 26785806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse childhood experiences and interaction with methamphetamine use frequency in the risk of methamphetamine-associated psychosis.
    Ding Y; Lin H; Zhou L; Yan H; He N
    Drug Alcohol Depend; 2014 Sep; 142():295-300. PubMed ID: 25064022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A systematic review of risk factors for methamphetamine-associated psychosis.
    Arunogiri S; Foulds JA; McKetin R; Lubman DI
    Aust N Z J Psychiatry; 2018 Jun; 52(6):514-529. PubMed ID: 29338289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prevalence of psychotic symptoms among methamphetamine users.
    McKetin R; McLaren J; Lubman DI; Hides L
    Addiction; 2006 Oct; 101(10):1473-8. PubMed ID: 16968349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lower folate levels in methamphetamine-induced psychosis: A cross-sectional study.
    Hadizadeh H; Salehi M; Bozorgnia AR; Ahmadkhaniha HR
    Drug Alcohol Depend; 2020 Feb; 207():107682. PubMed ID: 31841749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of persistent psychotic symptoms in persons with methamphetamine abuse receiving psychiatric treatment.
    Lecomte T; Mueser KT; MacEwan W; Thornton AE; Buchanan T; Bouchard V; Goldner E; Brink J; Lang D; Kang S; Barr AM; Honer WG
    J Nerv Ment Dis; 2013 Dec; 201(12):1085-9. PubMed ID: 24284645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of psychotic symptoms in subjects with methamphetamine versus cocaine dependence.
    Alexander PD; Gicas KM; Willi TS; Kim CN; Boyeva V; Procyshyn RM; Smith GN; Thornton AE; Panenka WJ; Jones AA; Vila-Rodriguez F; Lang DJ; William MacEwan G; Honer WG; Barr AM
    Psychopharmacology (Berl); 2017 May; 234(9-10):1535-1547. PubMed ID: 28190084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age at initiation of amphetamine use and age at onset of psychosis: the Australian Survey of High Impact Psychosis.
    Power BD; Stefanis NC; Dragovic M; Jablensky A; Castle D; Morgan V
    Schizophr Res; 2014 Jan; 152(1):300-2. PubMed ID: 24275582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychotic Symptoms in Attention-Deficit/Hyperactivity Disorder: An Analysis of the MTA Database.
    Vitiello B; Perez Algorta G; Arnold LE; Howard AL; Stehli A; Molina BS
    J Am Acad Child Adolesc Psychiatry; 2017 Apr; 56(4):336-343. PubMed ID: 28335878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.